跳至主要内容
临床试验/NL-OMON54597
NL-OMON54597招募中4 期

Study on Pharmacokinetics of newly developed ANtiretroviral agents in HIV-infected pregNAnt women (PANNA) - PANNA

Apotheek Klinische Farmacie0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
0 至 64(—)

入选标准

  • 1. HIV-infected as documented by positive HIV antibody test and confirmed by
  • Western Blot.
  • 2. Subject is at least 18 years of age at screening.
  • 3. Subject is able and willing to sign the Informed Consent Form prior to
  • screening evaluations.
  • 4. Treated with an HAART regimen containing at least one agent which is
  • mentioned in Appendix 1; this agent has been taken for at least 2 weeks before
  • the day of first PK curve evaluation.
  • 5. Duration of pregnancy not longer than 33 weeks at the day of screening
  • 6. Subject is able to adhere to food intake recommendations.

排除标准

  • 1. Relevant history or current condition that might interfere with drug
  • absorption, distribution, metabolism or excretion.
  • 2. Inability to understand the nature and extent of the study and the
  • procedures required.
  • 3. Presence of grade III/IV anemia (i.e. Hb <4.6 mmol/L or <7.4 g/dL)
  • 4. Using oral cabotegravir/rilpivirine.

研究者

发起方
Apotheek Klinische Farmacie

相似试验